Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Quest Diagnostics Incorporated DGX

Healthcare  —  Diagnostics & Research
236.32 (0.27) (0.11%) as of 25 Sep
Market cap
$26.2B
P/E
24.8×
S&P 500 Member Dividend Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Quest Diagnostics Incorporated (DGX) Price to free cash flow

As of 25 September 2026, Quest Diagnostics Incorporated (DGX) trades at a price to free cash flow of 19.4×. Over the past ten years it has ranged from 7.6× (June 2021) to 26.5× (December 2023); the current reading is higher than 93% of that period. That is below the Diagnostics & Research industry median of 34.0× and in line with the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 14.2× (23.06%)
FY2024 18.4× 0.92%
FY2023 18.3× 32.75%
FY2022 13.8× 16.36%
FY2021 11.8× 17.45%
FY2020 10.1× (40.72%)
FY2019 17.0× 22.46%
FY2018 13.9× (5.57%)
FY2017 14.7× (6.66%)
FY2016 15.7× (14.34%)

Quarterly

Period Price to free cash flow Change
Jun 2026 17.4× 7.27%
Mar 2026 16.3× 14.71%
Dec 2025 14.2× (7.50%)
Sep 2025 15.3× (6.78%)
42 more quarters

Against its own ten years

Low 7.6× High 26.5×
Ten-year median 16.2×
Current reading's percentile 93

Price to free cash flow against peers

Company Price to free cash flow
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated 19.4×
LH Labcorp Holdings Inc. compare 24.5×
MEDP Medpace Holdings, Inc. compare 24.7×
RVTY Revvity Inc. compare 29.8×
IDXX IDEXX Laboratories, Inc. compare 33.1×
MTD Mettler-Toledo International, Inc. compare 35.2×
ILMN Illumina, Inc. compare 44.9×
WAT Waters Corporation compare 116×
Diagnostics & Research industry median 34.0×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on DGX